BackChimerix Overview

Chimerix Total Assets

Chimerix's total assets is $150M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$146.01M
↓ 31.38% YoYΔ $-66.77M vs prior year quarter

Peer average

Loading

Chimerix Total Assets History

Loading

Chimerix vs. peers: Total Assets Comparison

Loading

Chimerix Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Chimerix (CMRX) FAQ

As of the most recent data (December 2024), CMRX shows a total assets of $150M. That compares with $210M in the prior-year period — down 31.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CMRX's total assets is now $150M (was $210M) — a 31.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Chimerix is outperforming or lagging.

Tracking CMRX's total assets over time shows whether Chimerix is scaling, shrinking, or reshaping that part of the business. The current reading is $150M That compares with $210M in the prior-year period — down 31.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Chimerix's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $150M) with ownership activity and broader fundamentals.

Chimerix's total assets is $150M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.